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Abstract. Recent evidence indicates there is a role for small mem-
brane vesicles, including exosomes, as vehicles for intercellular com-
munication. Exosomes secreted by most cell types can mediate
transfer of proteins, mRNAs, and microRNAs, but their role in the
transmission of infectious agents is less established. Recent studies
have shown that hepatocyte-derived exosomes containing hepatitis
C virus (HCV) RNA can activate innate immune cells, but the role
of exosomes in the transmission of HCV between hepatocytes
remains unknown. In this study, we investigated whether exosomes
transfer HCV in the presence of neutralizing antibodies. Puriﬁed exo-
somes isolated from HCV-infected human hepatoma HuH7.5.1 cells
were shown to contain full-length viral RNA, viral protein, and par-
ticles, as determined by RT-PCR, mass spectrometry, and transmis-
sion electron microscopy. Exosomes from HCV-infected cells were
capable of transmitting infection to naive human hepatoma
HuH7.5.1 cells and establishing a productive infection. Even with
subgenomic replicons, lacking structural viral proteins, exosome-
mediated transmission of HCV RNA was observed. Treatment with
patient-derived IgGs showed a variable degree of neutralization of
exosome-mediated infection compared with free virus. In conclusion,
this study showed that hepatic exosomes can transmit productive
HCV infection in vitro and are partially resistant to antibody neutral-
ization. This discovery sheds light on neutralizing antibodies resistantJournal of Hepatology 20
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Efﬁcient entry into cells is key for virus propagation. Unsurpris-
ingly, it is antagonized by the anti-viral armaments, such as neu-
tralizing antibodies that can block viral entry at different steps or
such as innate response sensors that decode structural features of
viral particles and trigger anti-viral responses in host cells. Sev-
eral cell entry routes and programs exist that seem to almost
invariably involve the initial attachment of viral particles to one
or several cellular receptors and/or entry factors. Explicitly, the
canonical entry process of enveloped viruses depends on viral
surface (glyco-)proteins for attachment to cells, and merging of
the viral membrane with cellular membranes by specialized
fusion proteins [1]. Yet, recent unveiling of virus seizure of spe-
ciﬁc cell membrane structures [2] and lipids [3] has highlighted
novel and highly original entry pathways.
Because the host defense arsenal efﬁciently targets various
entry steps of cell-free viral particles, viruses have evolved a
plethora of strategies to counteract or escape host immune mech-
anisms. For example, apart from conventional cell-free transmis-
sion by viral particles, hepatitis C virus (HCV), a prominent liver
disease pathogen, may use alternative itineraries for cell invasion
such as antibody-resistant cell-cell transmission routes [4] and
subterfuges such as camouﬂage with lipoprotein components,
as lipo-viro-particles, which also impairs antibody neutralization
[5]. Strikingly, a recent study by Ramakrishnaiah and colleagues
[6] inferred that hepatic exosomes transmit productive HCV
infection in vitro in a process that is partly resistant to antibody
neutralization and to antisera raised against some HCV entry
receptors (i.e., CD81, scavenger receptor class B member 1 (SR-
BI), and Claudin 1).
Exosomes are extracellular microvesicles of 30–150 nm in size
that are likely formed within multivesicular bodies (MVBs) – a
type of late endosome – and that are secreted in body ﬂuids
under normal and pathological conditions [7]. Exosomes contrib-
ute to many cell-cell communication processes, including trans-
fer of proteins, of mRNAs and microRNAs, or, within infected
organisms, to the transfer of pathogen-derived antigens and vir-
ulence factors [7]. Previous studies reported the presence of viral
RNA in exosomes isolated from plasma of HCV-infected patients
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[8]. A recent study demonstrated that full length HCV RNAs are
encapsulated within hepatocyte-derived exosomes and can be
transferred to plasmacytoid dendritic cells (pDC), where they
trigger IFN-a production [9]. The report by Ramakrishnaiah
et al. [6] is the ﬁrst to demonstrate an exosomal route of HCV
transmission between hepatocytes.
Interestingly, the mass spectrometric analysis of exosomes
puriﬁed from both naïve or HCV-infected HuH7.5.1 hepatoma
cells [6] revealed that they display both expected exosomal
markers and microRNAs but also ApoE and ApoB apolipoproteins
that, coincidently, are also usually present on bona ﬁde infectious
HCV particles [5], for which they mediate virion attachment to
cells independently of virus-encoded surface glycoproteins [10].
Importantly, exosomes puriﬁed from both infected HuH7.5.1 cells
and HCV subgenomic replicon (SGR) cells – that are devoid of
viral structural proteins and hence, do not assemble infectious
viral particles – contained complete HCV subgenomes that could
transmit HCV RNA and establish replication and/or infection in
HCV permissive naïve HuH7.5.1 cells. Exosomes isolated from
HCV SGR cells could induce viral replication in target cells less
efﬁciently than those produced from infected cells, likely owing
to reduced levels of viral RNAs in exosome-producer SGR cells.
Yet, this part of the study was essential since it allowed ﬁrm
demonstration of exosome-mediated HCV genome transmission
without the confounding effect of infectious viral particles that
may contaminate exosome preparations. Indeed, technically, it
is very challenging to totally exclude viral particles from isolated
exosome samples because density of the latter vesicles
(1.10–1.19 g/ml) partially overlaps with that of HCV particles
(from <1.06 to >1.16 g/ml in the blood of infected patients and
in the supernatants of infected cells [10]). This potential limita-
tion, as well as the possibility that exosomes may randomly pick
up HCV surface glycoproteins [6,8], may explain why the exoso-
mal transfer process of HCV was not completely resistant to neu-
tralizing antibodies. However, it is clear that a signiﬁcant part of
HCV exosomal transmission escapes neutralization since a high
proportion of sera from patients with chronic HCV exhibited lim-
ited inhibition of exosome-mediated infection, as compared to
HCV infectious particles, and since immunoglobulins puriﬁed
from patient’ sera not only did not neutralize exosomes isolated
from HCV SGR cells but, instead, could enhance their transmis-
sion. Additionally, since neutralizing antibodies are typically
directed against virus surface glycoproteins, these results directly
suggest that different processes are involved in HCV transmission
by genuine HCV particles vs. exosomes.
A recent study demonstrating that a non-enveloped virus,
hepatitis A virus, may conceal into exosomes to penetrate cells
and escape humoral immunity [2] further spices up the results
of Ramakrishnaiah et al. [6]. Exciting research addressing, e.g.,
the usurpation of cellular factors associated to MVB formation,
i.e., the endosomal sorting machineries for encapsidation and/or
transfer of viral elements [2,9] or the discovery of cell surface
molecule(s) involved in uptake and membrane fusion of exo-
somes will unravel the mechanisms of exosomal transmission
of HCV regarding the biogenesis of these fascinating vesiclesJournal of Hepatology 201and their entry process into target cells. Additionally, these ques-
tions will be important for understanding the contribution of
exosomes to the known immune escape properties of HCV and
to its dissemination or, conversely, to their capacity to stimulate
immune cells [9]. Conceivably, this may also lead to overcome
the unsuccessfulness of prophylactic neutralizing antibodies
and agents targeting the entry of HCV into cells.Financial support
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